Beta-Naphtoic Acid

Beta-Naphtoic Acid

SCHEMBL15021090

C=COCC.O=C(O)c1ccc2ccccc2c1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
ALDH1A1 P00352 2/20 0.51
HPGD P15428 2/20 0.51
MEN1 O00255 1/20 0.51
EGFR P00533 1/20 0.51
TP53 P04637 1/20 0.51
CYP3A4 P08684 1/20 0.51
MAPT P10636 1/20 0.51
PKM P14618 1/20 0.51
ALOX15 P16050 1/20 0.51
ALOX12 P18054 1/20 0.51
JAK1 P23458 1/20 0.51
MAPK1 P28482 1/20 0.51
KMT2A Q03164 1/20 0.51
HSD17B10 Q99714 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
NR1H4 Q96RI1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isophthalic Acid SCHEMBL6904865 0.83 KMT2A (0.49) KDM4ESMN1; SMN2ALDH1A1HPGDTP53
Beta-Naphtoic Acid SCHEMBL27913163 0.83 MEN1 (0.59) KDM4ESMN1; SMN2ALDH1A1HPGDMEN1
Benzoic Acid SCHEMBL4217226 0.82 DAO (0.52) SMN1; SMN2ALDH1A1MEN1TP53MAPT
Terephthalic Acid SCHEMBL6906820 0.82 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1TP53MAPT
Beta-Naphtoic Acid SCHEMBL27714607 0.81 KDM4E (0.53) KDM4ESMN1; SMN2ALDH1A1HPGDMEN1
Beta-Naphtoic Acid SCHEMBL20518217 0.79 KDM4E (0.67) KDM4ESMN1; SMN2ALDH1A1HPGDMEN1
Beta-Naphtoic Acid SCHEMBL727615 0.79 CES2 (0.65) KDM4ESMN1; SMN2ALDH1A1HPGDMEN1
Beta-Naphtoic Acid SCHEMBL30678321 0.79 CES2 (0.71) KDM4ESMN1; SMN2ALDH1A1HPGDMEN1
Beta-Naphtoic Acid SCHEMBL30678322 0.79 CES2 (0.71) KDM4ESMN1; SMN2ALDH1A1HPGDMEN1
Beta-Naphtoic Acid SCHEMBL29628843 0.79 CES2 (0.71) KDM4ESMN1; SMN2ALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765356-B2 Calixarene compound and photoresist composition comprising same DOW GLOBAL TECHNOLOGIES LLC (US) 2014-07-01 US disclosed
US-20130157195-A1 CALIXARENE COMPOUND AND PHOTORESIST COMPOSITION COMPRISING SAME ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130157195-A1 CALIXARENE COMPOUND AND PHOTORESIST COMPOSITION COMPRISING SAME CALU, UACA, HCAR1 KDM4E 1976/4885SMN1; SMN2 4563/4885ALDH1A1 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.